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Abstract
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) loci, together with cas (CRISPR–associated) genes, form
the CRISPR/Cas adaptive immune system, a primary defense strategy that eubacteria and archaea mobilize against foreign
nucleic acids, including phages and conjugative plasmids. Short spacer sequences separated by the repeats are derived
from foreign DNA and direct interference to future infections. The availability of hundreds of shotgun metagenomic
datasets from the Human Microbiome Project (HMP) enables us to explore the distribution and diversity of known CRISPRs
in human-associated microbial communities and to discover new CRISPRs. We propose a targeted assembly strategy to
reconstruct CRISPR arrays, which whole-metagenome assemblies fail to identify. For each known CRISPR type (identified
from reference genomes), we use its direct repeat consensus sequence to recruit reads from each HMP dataset and then
assemble the recruited reads into CRISPR loci; the unique spacer sequences can then be extracted for analysis. We also
identified novel CRISPRs or new CRISPR variants in contigs from whole-metagenome assemblies and used targeted
assembly to more comprehensively identify these CRISPRs across samples. We observed that the distributions of CRISPRs
(including 64 known and 86 novel ones) are largely body-site specific. We provide detailed analysis of several CRISPR loci,
including novel CRISPRs. For example, known streptococcal CRISPRs were identified in most oral microbiomes, totaling
,8,000 unique spacers: samples resampled from the same individual and oral site shared the most spacers; different oral
sites from the same individual shared significantly fewer, while different individuals had almost no common spacers,
indicating the impact of subtle niche differences on the evolution of CRISPR defenses. We further demonstrate potential
applications of CRISPRs to the tracing of rare species and the virus exposure of individuals. This work indicates the
importance of effective identification and characterization of CRISPR loci to the study of the dynamic ecology of
microbiomes.
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Introduction
CRISPRs, together with cas genes (CRISPR-associated genes),
provide acquired resistance against viruses and conjugative
plasmids [1,2], and are found in most archaeal (,90%) and
bacterial (,40%) genomes [3,4,5]. CRISPR arrays consist of 24–
47 bp direct repeats, separated by unique sequences (spacers) that
are acquired from viral or plasmid genomes [6]. Even though
some CRISPR arrays may contain hundreds of spacers (an
extreme case is the CRISPR array in the Haliangium ochraceum
DSM 14365 genome, which has 588 copies of its repeat), they tend
to be much smaller, generally with dozens of spacers. The repeat
sequences of some CRISPRs are partially palindromic, and have
stable, highly conserved RNA secondary structures, while others
lack detectable structures [7].
CRISPR arrays are usually adjacent to cas genes, which encode
a large and heterogeneous family of proteins with functional
domains typical of nucleases, helicases, polymerases, and polynu-
cleotide-binding proteins. CRISPR/Cas systems commonly use
repeat and spacer-derived short guide CRISPR RNAs (crRNAs) to
silence foreign nucleic acids in a sequence-specific manner [8,9].
CRISPR/Cas defense pathways involve several steps, including
integration of viral or plasmid DNA-derived spacers into the
CRISPR array, expression of short crRNAs consisting of unique
single repeat-spacer units, and interference with invading foreign
genomes at both the DNA and RNA levels, by mechanisms that
are not yet fully understood [8,10]. The diversity of cas genes
suggests that multiple pathways have arisen to use the basic
information contained in the repeat-spacer units in diverse defense
mechanisms. The CRISPR components are evolutionarily closely
linked and potentially evolve simultaneously as an intact locus—
sequence analysis reveals that the direct repeats in CRISPR locus
and the linked cas genes co-evolve under analogous evolutionary
pressure [11].
Previous studies have shown that CRISPR loci are very diverse
and abundant in the genomes of bacteria and archaea. In addition,
it has been shown that CRISPR loci with the same repeat
sequence and cas gene set can be found in multiple bacterial
species, implying horizontal gene transfer (HGT) [12]. Moreover,
CRISPR loci can change their spacer content rapidly, as a result of
interactions between viruses (or plasmids) and bacteria: several
metagenomic studies investigating host-virus population dynamics
have shown that CRISPR loci evolve in response to viral predation
and that CRISPR spacer content and sequential order provide
both historically and geographically insights [13,14,15,16]—
essentially, epidemiology.
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As a reflection of the infectious dynamics of microbial
communities, the study of CRISPRs is an essential compliment
to the study of the human microbiome, encompassing both disease
ecology and ecological immunology [17]. Infectious disease works
to maintain both species diversity [18,19] and genotypic diversity
[20] within a species, as has recently been shown for marine
microbiomes [21,22]. As such, infectious agents may be at least
partially responsible for the amazing species diversity and turnover
found throughout the human microbiome [23]. The ability of
CRISPR loci to prevent plasmid spread is medically relevant, in
that the exchange of conjugative elements is perhaps the dominant
mechanism by which antibiotic resistance genes (notably multi-
drug resistance) move within a biome, and by which pathogens
acquire resistance [24]; CRISPR activities could be expected to
retard this exchange (e.g. [25]).
CRISPR composition in human microbial communities, the
relative rate of CRISPR locus change, or how CRISPR loci vary
between different body sites and between the microbiota of
different individuals are less studied, as compared to other
environments. A recent analysis of streptococcal CRISPRs from
human saliva, in which CRISPR spacers and repeats were
amplified from salivary DNA, using the conserved streptococcal
CRISPR repeat sequence for priming, revealed substantial spacer
sequence diversity within and between subjects over time [26],
which is imagined to reflect the dynamics of phage and other
infectious agents in the human mouth [2].
The availability of more than 700 shotgun metagenomic
datasets from the Human Microbiome Project (HMP) enables us
to explore the distribution and diversity of many more CRISPRs,
and to discover new ones, across different body sites, in a
systematic manner. We developed a targeted assembly strategy
(see Figure 1) to better identify CRISPRs in shotgun metagenomic
sequences, as whole-metagenomic assembly failed to reconstruct
many CRISPRs that otherwise could be identified. All of the
programs available to date [27,28,29,30] are designed to find
CRISPRS from assembled contigs that are sufficiently long to
contain at least partial CRISPR loci; however, it is very difficult to
assemble metagenome reads into contigs containing CRISPR loci,
because of their repeated structures. We thus needed to collect
sequencing reads associated with CRISPRs and assemble them
specifically. For known CRISPRs (identified in reference ge-
nomes), we identified consensus sequences of CRISPR repeats,
collected the reads containing these sequences, and assembled
these reads into CRISPR contigs. We also identified CRISPRs
from the whole-metagenome assemblies, and for the novel
CRISPRs or new CRISPR variants (that are not seen in the
reference genomes), applied the same assembly strategy to achieve
a more comprehensive identification of the novel CRISPRs across
the samples. This approach allows us to study the evolution of
CRISPRs in human microbiomes.
Results
We identified and selected 64 known CRISPRs—including the
streptococcal CRISPR—from complete and draft bacterial
genomes and 86 novel CRISPRs from the 751 HMP whole-
metagenome assemblies, using metaCRT and CRISPRAlign (see
Methods). For each selected CRISPR, we then applied the
targeted assembly approach (for each CRISPR, first pool the reads
that contain the repeat, and then assemble the pooled reads only;
see Methods for a validation of the targeted assembly approach
using simulated datasets) to achieve a more comprehensive
characterization of the CRISPR loci in the human microbiome
shotgun datasets. Below we provide detailed analysis of the
targeted assembly approach, and the resulting CRISPR loci (listed
in Table 1 and Tables S1 and S2).
Targeted assembly improves the characterization of
CRISPRs
We first asked if our targeted assembly strategy helps to identify
CRISPR elements from metagenomic datasets, and found that it
greatly improved detection (see comparison in Table 2). The
improvements are twofold. First, the targeted assembly approach
identifies known CRISPRs in more human microbiome datasets,
as compared to the annotation of CRISPRs using whole-
metagenome assemblies. Second, targeted assembly resulted in
longer CRISPR arrays, from which we can extract many more
diverse spacers for analyzing the evolution of the CRISPRs and
other purposes. Here we use three examples to demonstrate the
performance of the targeted assembly.
The first example is the streptococcal CRISPR SmutaL36 (see
Table 1), a CRISPR that is conserved in streptococcal species such
as Streptococcus mutans [26]. This CRISPR was observed only in a
limited number of samples (38 out of 751 datasets) when using
contigs from whole-metagenome assembly. But our targeted
CRISPR assembly identifies instances of CRISPR SmutaL36 in
,10 times more (386) datasets. Consistent with the distribution of
streptococcus across body sites, most of the 386 datasets are from oral
samples: 120 of 128 supragingival plaques (94%), 128 of 135
tongue dorsum samples (95%), and 97 of 121 buccal mucosa
samples (80%) (see Table 3). CRISPR SmutaL36 was only found
in a small proportion of samples from other body locations, where
streptococcus rarely exists (e.g., 4 of 148 stool samples, and none of
the posterior fornix datasets). Table 2 shows the details of targeted
assembly of this CRISPR in two datasets.
The other two examples are GhaemL36 and SRS018394L37
(see details in Table 2). CRISPR GhaemL36 was initially
identified from the genome of Gemella haemolysans ATCC 10379
using metaCRT. Targeted assembly further identified instances of
this CRISPR in 258 oral-associated samples. The longest contig—
Author Summary
Human bodies are complex ecological systems in which
various microbial organisms and viruses interact with each
other and with the human host. The Human Microbiome
Project (HMP) has resulted in .700 datasets of shotgun
metagenomic sequences, from which we can learn about
the compositions and functions of human-associated
microbial communities. CRISPR/Cas systems are a wide-
spread class of adaptive immune systems in bacteria and
archaea, providing acquired immunity against foreign
nucleic acids: CRISPR/Cas defense pathways involve
integration of viral- or plasmid-derived DNA segments
into CRISPR arrays (forming spacers between repeated
structural sequences), and expression of short crRNAs from
these single repeat-spacer units, to generate interference
to future invading foreign genomes. Powered by an
effective computational approach (the targeted assembly
approach for CRISPR), our analysis of CRISPR arrays in the
HMP datasets provides the very first global view of
bacterial immunity systems in human-associated microbial
communities. The great diversity of CRISPR spacers we
observed among different body sites, in different individ-
uals, and in single individuals over time, indicates the
impact of subtle niche differences on the evolution of
CRISPR defenses and indicates the key role of bacterio-
phage (and plasmids) in shaping human microbial com-
munities.
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of 3121 bases—was assembled from the SRS019071 dataset. This
CRISPR array has even more repeats (48; i.e., 47 spacers) than the
CRISPR array in the Gemella haemolysans reference genome, which
has 29 repeats. CRISPR SRS018394L37 (currently not yet
associated with a host genome) was initially identified from the
whole-metagenome assembly of SRS018394, but targeted assem-
bly reveals the presence of this CRISPR in 238 oral-associated
microbiomes. The contig that was assembled in SRS049389 is the
longest one (2014 bps), containing 25 spacers.
In most cases we have tested, targeted assembly dramatically
improves the identification of CRISPRs in the HMP datasets: for
142 CRISPRs (out of 150), targeted assembly resulted in CRISPR
identification in more HMP samples as compared to using whole-
metagenome assemblies, and for 36 CRISPRs, targeted assembly
identified instances of the corresponding CRISPR in at least 10
times more datasets (see Table S1). It suggests that specifically
designed assembly approaches, such as the targeted assembly
approach for CRISPR assembly presented here, are important for
the characterization of functionally important repetitive elements
that otherwise may be poorly assembled in a whole-metagenome
assembly (which tends to be confused by repeats), and such a
comprehensive identification is important for deriving an unbiased
distribution of these functional elements across different body sites
among individuals.
Novel CRISPRs are found in human microbiome samples
In order to identify novel CRISPR loci, with which to seed
further targeted assemblies, we set out to find loci based simply on
the structural patterns of CRISPR loci, using the program
metaCRT, which we modified from CRT (see Methods). As a
result, we found and selected 86 different types of novel CRISPR
repeats in metagenomic samples, which could not be found in
reference genomes, for further targeted assembly (see Methods).
Table 1 lists selected examples of novel CRISPRs that we
identified in HMP datasets (see Table 1 for naming conventions).
A full list of CRISPRs (including the number of CRISPR contigs
assembled in each metagenomic dataset) is available as Table S1.
In this section, we highlight two examples of novel CRISPRs.
CRISPR SRS012279L38 was identified from a whole-meta-
genome assembly contig of dataset SRS012279 (derived from a
tongue dorsum sample; see Figure 2A). The identified CRISPR
contig has 6 copies of a 38-bp repeat (the last copy is incomplete;
see Table 1 for the consensus sequence of the repeats). De novo gene
prediction by FragGeneScan [31] reveals 10 protein-coding genes
in this contig, among which 9 share similarities with cas genes from
other genomes, including Leptotrichia buccalis DSM 1135
(NC_013192, an anaerobic, gram-negative species, which is a
constituent of normal oral flora [32]) and Fusobacterium mortiferum
ATCC 9817, by BLASTP search using the predicted protein
sequences as queries (see Figure 2B). (By contrast, BLASTX search
of this contig against nr database only achieved annotations for 7
genes). In addition, similarity searches revealed a single identical
copy of this repeat in the genome of Leptotrichia buccalis DSM 1135
(from 1166729 to 1166764; de novo CRISPR prediction shows that
this genome has several CRISPR arrays, including an array that
has 84 copies of a 29-bp repeat, but none of the CRISPRs have
Figure 1. A diagram of the targeted assembly approach for CRISPR.
doi:10.1371/journal.pgen.1002441.g001
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the same repeat sequence as SRS012279L38). These two lines of
evidence (similar cas genes, and an identical region in the genome)
suggest that the SRS012279L38 CRISPR we found in the human
microbiomes could have evolved from Leptotrichia buccalis or a
related species.
Targeted assembly of this novel CRISPR (SRS012279L38) in
HMP datasets resulted in 278 contigs from 97 datasets, confirming
the presence of this CRISPR in human microbiomes. In
particular, the CRISPR fragments (407 bps) identified from the
whole-metagenome assembly of SRS012279 were assembled into
a longer CRISPR contig (890 bps) by targeted assembly. A total of
14 unique but related repeat sequences were identified from 278
CRISPR contigs, and two of them (which differ at 3 positions) are
dominant, constituting 71% of the repeats in the CRISPR contigs.
Notably, all the repeats could be clustered into a single consensus
sequence with an identity threshold of 88%. By contrast, the
spacer sequences are very diverse across different samples. For
example, we obtained a total of 352 unique spacer sequences,
which were clustered into 345 consensus sequences with an
identity threshold of 90%. Among 352 unique spacers, 114 spacer
sequences were shared by multiple samples—a single spacer was
shared by at most eight samples.
The second example is CRISPR SRS023604L36, initially
identified in a whole-metagenome assembly contig of dataset
SRS023604 (derived from posterior fornix), which has 5 copies of
a 36 bp repeat (see consensus sequence of the CRISPR repeat in
Table 1). Targeted assembly of this CRISPR across all HMP
metagenomic datasets revealed further instances of this CRISPR
in several other datasets, including two from stool, and two from
posterior fornix. Moreover, the CRISPR contig was assembled
into a longer contig of 778 bps containing 12 copies of the
CRISPR repeat. BLAST search of the CRISPR repeat against the
nr database did not reveal any significant hits.
Expanding the CRISPR space by human microbiomes
To investigate how much the CRISPRs identified in the HMP
datasets can expand the CRISPR space (sequence space of the
CRISPR repeats), we built a network of CRISPRs, based on the
sequence similarity between CRISPR repeats. An edge in the
network between two CRISPR repeats, each represented by a
node, indicates that the two repeats can be transformed from one
to another by at most 10 operations (including mutations,
insertions, and deletions). Since it is difficult to determine the
direction of CRISPR repeats [7] (especially for the CRISPR arrays
that have incomplete structures), given two repeats, we calculated
two edit distances—one is the distance between the two repeats,
and the other one is between one repeat and the reverse
complement of the other—and used the smaller value as the edit
distance between the two repeats. The global network (Figure 3A;
see Figure S1 with node labels) shows that most of the novel
CRISPRs identified in the human microbiomes are remotely
related to ones identified in complete (or draft) genomes. Still,
there are small clusters that contain only novel HMP CRISPRs,
indicating that these CRISPRs are substantially different from
ones identified in the reference genomes. In Figure 3B, we have
colored nodes by body site: while specific CRISPR repeats can be
highly specific to body site (see below), the larger families of repeats
shown in Figure 3B do not appear to cluster based on body site.
We further studied the sequence patterns of the repeats for each
group and our results show 1) distinct patterns among the groups,
and 2) high conservation around the stem and start/end positions
in CRSIPR repeats of each group (see sequence logos—for the
large groups—in Figure S2). The consensuses revealed by the
logos show consistencies with the results in a previous study, which
used a similar approach, based on alignments of CRISPR repeats,
for classification of CRISPR repeats [7].
CRISPRs have diverse distributions across human body
sites and individuals
Overall, the distributions of CRISPRs are largely body-site
specific (see Figure 4 and Figure S3; the name of CRISPR and the
number of samples in which the CRISPR was found are listed in
Table S3). For example, CRISPRs AhydrL30 ad BcoprL32 are
only found in stool samples (see Table 3). Exceptions include two
CRISPRs that were found from both a significant number of gut-
and oral-associated samples: Neis_t014_L28 were found in 51 gut
samples and 92 oral-associated samples; FalocL36 identified from
Table 1. List of selected CRISPRs discussed in the paper.
IDa
Species (or HMP sample ID)
Consensus sequence of the CRISPR repeats
Known
AhydrL30 Anaerococcus hydrogenalis DSM 7454 (NZ_ABXA01000037)
ATTTCAATACATCTAATGTTATTAATCAAC
AlactL29 Anaerococcus lactolyticus ATCC 51172 (NZ_ABYO01000191)
AGGATCATCCCCGCTTGTGCGGGTACAAC
BcoprL32 Bacteroides coprophilus DSM 18228 (NZ_ACBW01000156)
GTCGCACCCTGCGTGGGTGCGTGGATTGAAAC
FalocL36 Filifactor alocis ATCC 35896 (NZ_GG745527)
TTTGAGAGTAGTGTAATTTCATATGGTAGTCAAAC
GhaemL36 Gemella haemolysans ATCC 10379 (EQ973306)
GTTTGAGAGATATGTAAATTTTGAATTCTACAAAAC
LcrisL29 Lactobacillus crispatus ST1 (NC_014106)
AGGATCACCTCCACATACGTGGAGAATAC
LjassL36 Lactobacillus gasseri JV-V03 (NZ_ACGO01000006)
GTTTTAGATGGTTGTTAGATCAATAAGGTTTAGATC
LjensL36 Lactobacillus jensenii 115-3-CHN (NZ_GG704745)
GTTTTAGAAGGTTGTTAAATCAGTAAGTTGAAAAAC
Neis_t014_L28 Neisseria sp. oral taxon 014 str. F0314 (NZ_GL349412)
GTTACCTGCCGCACAGGCAGCTTAGAAA
Neis_t014_L36 Neisseria sp. oral taxon 014 str. F0314 (NZ_GL349412)
GTTGTAGCTCCCTTTCTCATTTCGCAGTGCTACAAT
PacneL29 Propionibacterium acnes J139 (NZ_ADFS01000004)
GTATTCCCCGCCTATGCGGGGGTGAGCCC
PpropL29 Pelobacter propionicus DSM 2379 (NC_008609)
CGGTTCATCCCCGCGCATGCGGGGAACAC
SmutaL36 Streptococcus mutans NN2025
GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC
Novel
SRS012279L38 SRS012279 (dataset from a tongue dorsum sample)
TATAAAAGAAGAGAATCCAGTAGAATAAGGATTGAAAC
SRS018394L37 SRS018394L37 (dataset from a supragingival plaque sample)
GTATTGAAGGTCATCCATTTATAACAAGGTTTAAAAC
SRS023604L36 SRS023604 (dataset from a posterior fornix sample)
GTTTGAGAGTAGTGTAATTTATGAAGGTACTAAAAC
aThe IDs of the CRISPRs are assigned using the following rules: 1) If a CRISPR
(e.g., SmutaL36) is identified from a known complete/draft genome with species
name (for SmutaL36, the genome is Streptococcus mutans NN2025), its ID uses
five letters from the species name (i.e., Smuta) followed by the length of the
repeats (length of 36 is shown as L36); 2) If a CRISPR (Neis_t014_L28) is
identified from a known complete/draft genome that has only general genus
information (e.g., Neisseria sp. oral taxon 014 str. F0314), then its ID is four letters
from the genus name, followed by the taxon ID, and the length of the repeats;
and 3) the CRISPRs identified in the HMP datasets are named as the ID of the
datasets followed by the length of repeat.
doi:10.1371/journal.pgen.1002441.t001
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Filifactor alocis ATCC 35896 were found in 63 gut samples and 72
oral-associated samples, including 50 tongue dorsum samples (see
Table 3).
The first 50 CRISPRs shown in Figure 4 are mainly found in
stool samples. AshahL36, which was initially identified from
Alistipes shahii WAL 8301, was found in more than half of gut-
related samples (96 out of 147 samples). On the other hand, 99
CRISPRs are mainly found in oral samples, in particular, tongue
dorsum, supragingival plaque, and buccal mucosa. We found 5
CRISPRs that exist in more than half of the oral-associated
samples (out of 417): SmutaL36, KoralL32 from Kingella oralis
ATCC 51147, Veil_sp3_1_44_L36 and Veil_sp3_1_44_L35 from
Veillonella sp. 3_1_44, and SoralL35 from Streptococcus oralis ATTC
35037. 4 CRISPRs are mostly found in vaginal samples (AlactL29,
LjensL36, LjassL36, and LcrisL29). 1 CRISPR is skin-specific
(PacneL29), found mainly in skin samples. Below we discuss the
body-site distributions of a few examples.
Neis_t014_L28 and Neis_t014_L36 are inferred from a single
genome, Neisseria sp. oral taxon 014 str. F0314, but these two
CRISPRs show distinct absence/presence profiles across body
sites (see Table 3). For stool samples, there exists only CRISPR
Neis_t014_L28 in 51 datasets, but not Neis_t014_L36. And
Neis_t014_L36 is relatively more prevalent in oral-associated
samples as compared to Neis_t014_L28. The different body site
distributions can be explained by the fact that these two CRISPRs
are found in different sets of genomes (although both can exist in a
common genome, Neisseria sp. oral taxon 014 str. F0314).
Neis_t014_L36 has been identified in multiple Neisseria genomes,
including Neisseria meningitidis ATCC 13091, Neisseria meningitidis
8013 (so Neis_t014_L36 belongs to the Nmeni subtype among the
8 subtypes defined by Haft et al [33]), Neisseria flavescens SK114,
and Actinobacillus minor NM305. Neis_t014_L28, however, was only
found in Neisseria sp. oral taxon 014 str. F0314. On the other hand,
even though we could not find any CRISPRs containing the
exactly same repeat as Neis_t014_L28 in the complete/draft
genomes other than Neisseria sp. oral taxon 014 str. F0314, many
CRISPRs, when a few mismatches are allowed, were found in
diverse genomes (for example, Crenothrix polyspora, Legionella
pneumophila 2300/99 Alcoy, and Thioalkalivibrio sp. K90mix) from
environmental samples.
Four CRISPRs (AlactL29, LjensL36, LjassL36, and LcrisL29)
exist mostly in vaginal samples. AlactL29, initially identified from
the Anaerococcus lactolyticus genome, was found only in 3 vaginal
samples. Notably, LjensL36 was found in 28 vaginal samples
Table 2. Comparison of CRISPR identification using whole-metagenome assembly and targeted assembly.
Whole-metagenome assembly Targeted assembly
CRISPR Sample datasets Spacers (max) Spacers (total) Short reads Spacers (max) Spacers (total)
SmutaL36 (386a vs 38b) SRS017025 (plaque) 1c 1d 1078e 26 76
SRS011086 (tongue) 1 2 4018 24 78
GhaemL36 (257 versus 9) SRS019071 (tongue) 0 0 1718 47 21
SRS014124 (tongue) 3 3 490 21 58
SRS018394L37 (238 versus 39) SRS049389 (tongue) 0 0 5778 25 492
SRS049318 (plaque) 1 1 1463 38 134
athe total number of samples that have streptococcal CRISPRs identified if using targeted assembly, and
bif using whole-metagenome assembly;
cthe total number of spacers found in the longest CRISPR locus found in the given dataset;
dthe total number of spacers found in all contigs assembled from the given dataset;
ethe total number of sequences that contain the repeats of a given CRISPR, i.e., the recruited reads used for targeted assembly. See Table S1 for comparison of all the
CRISPRs studied in this paper.
doi:10.1371/journal.pgen.1002441.t002
Table 3. Distribution of selected CRISPRs across body sites.
Oral Skin
CRISPR
Anterior
nares (94a)
Stool
(148)
Buccal
mucosa (121)
Supra-gingival
plaque (128)
Tongue
dorsum (135)
Posterior
fornix (61) L- (9)c R- (18)d
SmutaL36 11b 4 97 120 128 0 0 1
AhydrL30 0 53 0 0 0 0 0 0
BcoprL32 0 65 0 0 0 0 0 0
FalocL36 0 63 1 18 50 0 0 0
Neis_t014_L28 0 51 15 58 15 0 0 0
Neis_t014_L36 0 0 37 66 82 0 0 0
PacneL29 1 0 0 0 0 0 4 7
athe total number of datasets;
bthe total number of datasets that have CRISPRs identified;
cL-Retroauricular crease;
dR-Retroauricular crease. Note not all body sites are listed in this table.
doi:10.1371/journal.pgen.1002441.t003
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(which comprise 43% of vaginal samples collected) and 1 skin
sample. This observation is consistent with a previous study
showing that Lactobacillus constitutes over 70% of all bacteria
sampled from vaginas of healthy, fertile women, and Lactobacillus
jensenii is one of the major genomes [34]. Interestingly, we could
find evidence of adaptation in the LjensL36 spacer against
Lactobacillus phage Lv-1 (NC_011801) (see below). LjassL36 was
found in 33 vaginal samples by targeted assembly. We confirmed
that it is in different Lactobacillus genomes, such as Lactobacillus
gasseri and Lactobacillus crispatus, by BLAST search. CRISPR
LcrisL29, which was identified in the Lactobacillus crispatus genome,
was found in 31 vaginal samples, and we found the same repeat
sequence in the Lactobacillus helveticus genome.
PacneL29 was the only skin-specific CRISPR we found in the
HMP datasets. Interestingly, instances of PacneL29 are found in
Propionibacterium acnes HL110PA4 and Propionibacterium acnes J139,
but not other P. acnes isolates (including KPA171202, SK137,
J165, and SK187). This indicates a potential application of
CRISPRs in the characterization of specific stains for a species in
human microbiomes.
CRISPRs have very diverse spacers
The HMP project enables us to explore the diversity of
streptococcal CRISPRs (and others) at a much broader scale (with
751 samples from 104 healthy individuals). The CRISPRs that we
identified in human microbiomes exhibited substantial sequence
diversity in their spacers among subjects. Targeted assembly of the
streptococcal CRISPRs (SmutaL36) in HMP datasets resulted in a
total of 15,662 spacers identified from 386 samples, among which
7,815 were unique spacers (clustering of the spacers at 80%
identify resulted in a non-redundant collection of 7,436 sequences).
See Figure S4 for the sharing of the spacers in streptococcal
CRISPRs among all individuals, which shows several large clusters
of spacers that are shared by multiple individuals (for clarity, we
only keep spacers that were shared by more than eight samples in
this figure). In particular, the most common spacer is shared by 25
individuals (in 32 samples).
More importantly, we could check the sharing of CRISPR
spacers across different body sites and sub-body sites (e.g., multiple
oral sites) using HMP datasets (Pride et al. examined streptococcal
CRISPRs in saliva samples from 4 individuals [26]). Figure 5
shows the spacer sharing among 6 selected individuals, each of
whom has multiple samples with identified streptococcal CRISPRs
from multiple body sites (see Figure S5 for the spacer sharing with
spacers clustered at 80% sequence identify). By examining the
distribution of the spacers across samples, we observed that
samples re-sampled from the same individual and oral site shared
the most spacers, different oral sites from the same individual
shared significantly fewer, while different individuals had almost
no common spacers, indicating the impact of subtle niche
differences and histories on the evolution of CRISPRs. Our
observation is largely consistent with the conclusion from Pride et
al. [26]. But our study showed that different samples from the same
oral site of the same person, even samples collected many months
Figure 2. A potentially novel CRISPR array identified in a contig (9848 bases) from sample SRS012279. (A) This CRISPR array has 6
copies of the repeat (repeat sequences shown in red font and spacer shown in blue). (B) shows our annotation of this contig, in which the CRISPR
array is highlighted in red. We first predicted ORFs in this contig using FragGeneScan [31], and then blasted predicted proteins against the nr protein
database to retrieve annotations; for example, the predicted Cas1 is similar to the Cas1 protein identified in Leptotrichia buccalis C-1013-b (accession
ID: YP_003163976), with 60% sequence identify and 80% sequence similarity.
doi:10.1371/journal.pgen.1002441.g002
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Figure 3. Visualizations of the CRISPR network of 150 CRISPRs, each represented as a node. There is an edge between two nodes, if the
edit distance between the consensus sequences of the repeats of the corresponding CRISPRs is ,10, with edges of small edit distances (i.e., the two
CRISPRs share more similar repeats) shown in thick lines and edges of larger edit distances in thin lines. In (A), the known CRISPRs are shown as blue
nodes (except for several CRISPRs highlighted in green), and the novel CRISPRs identified in the HMP datasets are shown as red nodes. In (B), the
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apart, could still share a significant number of spacers (e.g., the
supragingival plaque samples from individual 1 in visit 1 and visit
2, with 238 days between the two visits, and the tongue dorsum
samples from individual 5 in visit 1 and visit 3, with 336 days
between the two visits; as shown in Figure 5). Our study also
showed that although the different oral sites of the same individual
share similar spacers, this sharing (e.g., between the supragingival
plaque sample and the buccal mucosa sample for individual 1) is
minimal, as compared to the spacer sharing between samples
collected in different visits but from the same oral site (e.g., between
the supragingival plaque samples from visit 1 and visit 2 for
individual 1). Finally, our study shows that the spacer turnover
varies among individuals—for the 6 selected individuals, individ-
ual 3 shows significantly higher turnover of the spacers between
visits, as compared to other individuals.
We also checked the spacer diversity for the CRISPR
KoralL32, since it and its variants are one of the most abundant
CRISPRs. This CRISPR was assembled from 339 samples: 327
from oral sites and 2 from gut. The targeted assembly of KoralL32
found 7282 unique spacers, among which the most commonly
shared spacer is shared by 35 individuals (in 58 samples). Figure S6
shows the sharing of the spacers among the individuals for this
CRISPR, which shows similar spacer-sharing patterns as those
found in the streptococcal CRISPRs.
The similarity between spacers from the same individual
suggests that we may still be able to trace the evolution of
CRISPRs, especially in the same body site of the same individual,
even though the CRISPR loci tend to have extremely high
turnover of their spacers.
CRISPR spacer sequences can be used to trace the viral
exposure of microbial communities
As a consequence of CRISPR adaptation, the spacer contents in
CRISPR arrays reflect diverse phages and plasmids that have
passed through the host genome [1,35,36,37]. However, previous
studies have shown that only 2% of the spacer sequences have
matches in GenBank, which is probably due to the fact that
bacteriophage and plasmids are still poorly represented in
databases [13,14]. Similarity searches of identified spacers against
viral genomes enable identification of the viral sources of the
spacers (i.e., proto-spacers) captured in each CRISPR locus. For
example, similarity searches of the 7,815 unique spacers in the
streptococcal CRISPR against viral genomes revealed similarities
between streptococcal spacers and 22 viral genomes (species
names and accession IDs are listed in Table S4), and the two most
prevalent viruses are Streptococcus phage PH10 (NC_012756) and
Streptococcus phage Cp-1 (NC_001825) (see Figure 6A). Figure 6B
suggests that the potential proto-spacers are rather evenly
distributed along the phage genomes (except for a few regions,
including a region that encodes for an integrase, which is
highlighted in red in Figure 6B). Although the positional
distribution of the proto-spacers is close to random, the sequences
adjoining the proto-spacers for streptococcal CRISPR we identi-
fied in the virus genomes showed conserved short sequence motifs
(GG) (see Figure S7 for the sequence logo), which is also the most
common proto-spacer adjacent motif (PAM) shared by several
CRISPR groups, as reported in [38].
Another example is CRISPR PacneL29, which is mainly found
in skin-associated microbiomes. BLAST search of the identified
spacers against the virus genome dataset revealed similarity
between the spacers and several regions in Propionibacterium phage
PA6 (NC_009541). We also found evidence of adaptation in
LjensL36 against Lactobacillus phage Lv-1 (NC_011801): BLAST
search shows significant matches to a total of 38 regions in the
phage genome. Overall we found 23 CRISPRs that have spacers
with high sequence similarities ($90% over 30 bps) with virus
genomes collected from the NCBI ftp site (Table S5).
We also searched the spacers against plasmid sequences
(collected in the IMG database). For example, matches were
found between the detected streptococcal CRISPR spacers and
nodes are colored based on body site, in which the CRISPRs are most frequently found. CRISPRs are assigned as rare if they were found in ,5
samples; otherwise, they are assigned to particular body site(s) if they are found in more than 10 percent of the samples for that particular body site
(e.g., stool+skin). The figures were prepared using Cytoscape [43].
doi:10.1371/journal.pgen.1002441.g003
Figure 4. Distribution of CRISPRs across body sites. In this figure, the x-axis represents 150 CRISPRs and the y-axis represents the total number
of samples in which instances of each CRISPR are found. Note that there are roughly one third as many stool samples as oral samples, probably
explaining the apparently smaller number of CRISPRs in the gut microbiome. See Table S3 for details of the distribution of CRISPRs across body sites.
doi:10.1371/journal.pgen.1002441.g004
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more than 10 plasmid sequences (including Streptococcus thermophilus
plasmid pER35, pER36, pSMQ308, and pSMQ173b; Bacillus
subtilis plasmid pTA1040; and Streptococcus pneumoniae plasmids
pSMB1, pDP1 and pSpnP1). See Table S6 for a summary of the
plasmids that share high homology with the CRISPR spacers.
The CRISPER spacers can also be used to identify viral contigs
in metagenome assemblies that contain proto-spacers. As an
example, similarity searches of identified streptococcal CRISPR
spacers against the HMP assemblies revealed 37 potential viral
contigs (of lengths from 2,134 to 56,413 bp): these contigs show
high homology (.80% sequence similarity) with known viral
genomes. The largest contig (of 56,413 bps) is similar to the
genome of Streptococcus phage Dp-1 (NC_015274), with 88%
sequence identify, and covers almost the entire viral genome (of
59,241 bps). A future paper will fully explore this approach.
Conserved CRISPR repeat sequences can be used to
reveal rare species in human microbiome
Because of the large number of repeats that many CRISPR loci
contain, CRISPR repeats of rare species with low sequence
coverage in a community can still be found. It was reported that
repeat-based classification [7] corresponds to a cas gene-based
classification of CRISPRs [33], which revealed several subtypes of
CRISPRs largely constrained within groups of evolutionarily
related species (e.g., the Ecoli subtype). As such, we may use the
presence of the repeats of a particular CRISPR as a first indication
of the presence of related genome(s) in a microbiome, even though
CRISPR locus has been found transferred horizontally as a
complete package among genomes [11].
We use CRISPR PpropL29 as an example to demonstrate this
potential application, as PpropL29 was identified in only a small
proportion of the HMP samples (11 datasets): including 7
supragingival plaque samples (out of 125) and 4 tongue dorsum
samples (out of 138). All the PpropL29-related repeats identified in
these samples can be clustered into 7 unique sequences. In order to
find the most likely reference genomes for these 7 unique repeat
Figure 5. Sharing of streptococcal CRISPR spacers among
samples from 6 individuals. In this map, the rows are the 761
spacers (clustered at 98% identify) identified in one or more of these 6
individuals, and the columns are samples (e.g., Stool_v1_p1 indicates a
sample from stool of individual 1, in visit 1; Tongue_v2_p1 indicates
dataset from tongue, individual 1, in visit 2). Buccal stands for buccal
mucosa, and SupraPlaque stands for supragingival plaque. The red lines
indicate the presence of spacers in each of the samples. Multiple lines in
the same row represent a spacer that is shared by multiple samples.
doi:10.1371/journal.pgen.1002441.g005
Figure 6. Traces of viral sequences in the streptococcal
CRISPRs in human microbiomes. (A) A two-way clustering of viral
genomes and the HMP datasets based on the presence patterns of viral
sequences in the CRISPR loci identified in the HMP datasets: the
columns are the viral genomes, and the rows are HMP datasets. It shows
that the genome of Streptococcus phage PH10 (NC_012756) has the
most regions that are similar to the spacers in streptococcal CRISPRs.
This figure was prepared using the heatmap function in R, with the
default clustering method (hclust) and distance measure (Euclidean). (B)
Mapping of the spacers onto the 31,276 base genome of Streptococcus
phage PH10; in this figure, each vertical line shows a potential proto-
spacer, a region in the virus genome that is similar to a spacer found in
HMP datasets; lines of the same color show sets of proto-spacers
identified from the same HMP dataset (other individual proto-spacers
are shown in gray lines); the ORFs are shown in arrows (the red arrow is
an integrase and the green arrow is annotated as endolysin).
doi:10.1371/journal.pgen.1002441.g006
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sequences, we blasted these repeat sequences against the human
microbiome reference genomes and found 100% identity matches
in the Lautropia mirabills genome. To investigate the overall
coverage of this genome by the reads (not only the CRISPR
regions), we mapped the entire collection of reads from four
samples: SRS019980 and SRS021477 (both are from supragingi-
val plaque, and have an 100% identity match with the CRISPR
repeat in the Lautropia mirabills genome); SRS019974 (from tongue
dorsum, with a slightly different CRISPR repeat sequence with 3
differences); and SRS019906 (which does not contain any
CRISPR repeats similar to PpropL29, used as a control). The
mapping results show the reads from two samples SRS019980 and
SRS021477 each cover ,80% of the Lautropia mirabills genome,
which is very significant evidence that these two microbiomes
include Lautropia mirabills. But the other two samples have only a
limited number of reads mapped to the genome (e.g., only 3089,
reads in SRS019906 were mapped into Lautropia mirabills). This
contrast suggests that identification of CRISPRs by targeted
assembly could provide significant evidence for the existence of
certain rare genomes.
Discussion
We have applied a targeted assembly approach to CRISPR
identification, to characterize CRISPRs across body sites in
different individuals. Our studies show that a directed approach—
such as our targeted assembly approach—is important for a
comprehensive (thus less biased) estimation of the distribution of
CRISPRs across body sites and individuals, and their dynamics.
Note that in this study, we only focused on CRISPRs identified in
eubacterial genomes, since archaea are rare in human micro-
biomes (we looked for, but did not find, archaeal CRISPRs in the
HMP assemblies). Also for the sake of simplicity, we derived a non-
redundant list of CRISPRs based on the similarity of the CRISPR
repeats (see Methods), and detailed targeted assembly was only
applied to these CRISPRs.
Although many CRISPR arrays may be missed by whole-
metagenome assembly, we show that whole-metagenome assem-
blies are useful for identifying novel CRISPRs (as de novo prediction
of CRISPRs relies on sequence features of CRISPRs that do not
exist in short reads). Once seeding CRISPRs are identified from
whole-metagenome assemblies, we can go back to the original
short read datasets, and pursue a comprehensive characterization
of the CRISPRs, using the targeted assembly approach. Also, we
did not fully utilize the presence of cas genes for identification of
novel CRISPRs in our study, since in many cases we can identify
arrays of repeats, but not their associated cas genes. A future
direction is to combine targeted assembly of CRISPRs and whole-
metagenome assembly, aiming to achieve even better assembly of
the CRISPR loci with more complete structures, including cas
genes and the arrays of repeats and spacers. Such an improvement
is necessary to achieve a more comprehensive characterization of
especially the novel CRISPRs discovered in metagenomes, and the
temporal order of spacer addition to arrays.
The immediate utility of this study is to provide more complete
inventories of CRISPR loci in human microbiomes and their
distributions in different human body sites, and the spacer content
of these loci. The identification of CRISPR spacers opens up
several potential applications, including tracing the viral exposure
of the hosts, studying the sequence patterns of the regions
adjoining the spacer precursors in viral genomes, and discovering
viral contigs in metagenome assemblies. It has been shown that
short sequence motifs found in the regions adjacent to the spacer
precursors in the viral genomes determine the targets of the
CRISPR defense system [38], and we were able to analyze the
sequence patterns of regions adjacent to spacer precursors for
several CRISPRs with the most spacers identified in the HMP
datasets (including SmutaL36, LjensL36, and KoralL32; see
sequence logos in Figure S7). When more metagenomic datasets
become available, we will extend the analysis to more CRISPRs,
which may provide insights into the mechanism of the CRISPR
defense system (including the turnover patterns of the CRISPR
spacers, and the target recognition of the CRISPR defense
systems). Our preliminary exploration of viral contigs—by
searching CRISPR spacers against whole-metagenome assem-
blies—suggests that we can identify new virus genomes in
metagenome assemblies; further computational and experimental
analysis will be needed to confirm these contigs.
We look forward to being able to utilize CRISPR spacer
sequences to understand human and human microbiome biology
better, utilizing the metadata associated with the HMP datasets.
This awaits a more complete sampling of individuals over time,
and of known relationships; and a far better characterization of
bacteriophage and other selfish genetic elements in the human
biome (our inventory of spacers is a standard against which phage
and plasmid collections can be judged).
Methods
De novo identification of CRISPRs
CRT [28] is a tool for fast, de novo identification of CRISPRs in
long DNA sequences. CRT works by first detecting repeats that
are separated by a similar distance, and then checking for other
CRISPR specific requirements (e.g., the spacers need to be non-
repeating and similarly sized). We modified CRT to consider
incomplete repeats at the ends of contigs from whole-metagenome
assembly, and call the modified program metaCRT.
Identification of CRISPRs by similarity search
We implemented CRISPRAlign for identifying CRISPRs in a
target sequence (a genome or a contig) that has repeats similar to a
given CRISPR (query CRISPR). CRISPRAlign works by first
detecting substrings in the target sequence (or its reverse
complement) that are similar to the repeat sequence of a query
CRISPR, and then checking for other requirements, as in
metaCRT. Both metaCRT and CRISPRAlign are available for
download at http://omics.informatics.indiana.edu/CRISPR/.
Selection of known and novel CRISPRs for targeted
assembly in HMP datasets
Using metaCRT and CRISPRAlign, we prepared a list of
known CRISPRs repeats (identified from complete/draft bacterial
genomes) and a list of potentially novel ones (identified only in the
whole-metagenome assemblies from the HMP datasets) for further
detailed study of their distributions among the HMP datasets. As
we show in Results, the targeted assembly strategy is important for
an efficient and comprehensive characterization of these CRISPRs
in human microbiome datasets.
Known CRISPRs were first identified from the bacterial
genomes (or drafts) collected in the IMG dataset (version 3.3),
using metaCRT. We then selected a subset of the identified
CRISPRs that meet the following requirements: direct repeats are
of length 24–40 bps, there are a minimum of 4 copies of the direct
repeats, and the individual repeats each differ by at most one
nucleotide from the repeat consensus sequence, on average. The
parameters were chosen to minimize false CRISPRs, considering
that a CRISPR array typically contains 27 repeats, with an
average repeat length of 32 base pairs [28]. We only kept
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CRISPRs that can be found in at least one of the whole-
metagenome assemblies, using CRISPRAlign. We further reduced
the number of candidate CRISPRs by keeping only those that
share at most 90% sequence identity along their repeats by CD-
HIT [39], as there are CRISPRs that share very similar repeats,
and our targeted assembly strategy can recover the CRISPRs with
slight repeat differences. To avoid including a repeat and its
reverse complete (metaCRT does not consider the orientation for
the repeats) in the non-redundant list, we included reverse
complement sequences of the CRISPR repeats in the clustering
process. Therefore, a repeat would be classified into two clusters
by CD-HIT (the reverse complete of the repeat would be classified
into a different cluster), one of which was removed to reduce
redundancy.
We consider that a CRISPR identified in the HMP assemblies is
novel if we find no instances of this CRISPR in the IMG bacterial
genomes and the HMP reference genomes, with at most 4
mismatches using CRISPRAlign. Similarly, we only kept a non-
redundant list of the novel candidates.
In total, we selected a collection of non-redundant CRISPRs—
including 64 known CRISPRs and 86 novel ones—for further
targeted assembly from HMP shotgun reads. The detailed
information for these CRISPRs (repeat sequences, and their
resources, and the references for the CRISPRs already collected in
the CRISPRdb database http://crispr.u-psud.fr/ [6]), is provided
in Tables S1 and S2.
Targeted assembly of CRISPRs
For the targeted assembly of CRISPRs, we first carried out a
BLASTN search with each putative CRISPR repeat sequence as
the query, to collect reads that contain the repeat sequence (see
Figure 1). In order to make the similarity search tolerant to
sequencing errors and genomic variations that are observed among
the multiple copies of a CRISPR repeat (in one CRISPR locus or
between different CRISPR loci), we allowed three mismatches over
the entire CRISPR repeat sequence: we retained only the reads that
are aligned with the entire CRISPR repeat sequence with a
maximum of three mismatches. With these reads containing
CRISPR repeat sequences, we ran SOAPdenovo [40] with k-mers
of 45 bps, which are sufficiently long to assemble reads with the
repetitive sequences found in CRISPRs. In general, whole-
metagenome contigs are assembled using shorter k-mers (for
example, 21–23 bps in MetaHit [41] and 25 bps in HMP assembly
[42]), as longer k-mers often fragment assemblies into short contigs.
After CRISPR contigs were assembled, the exact boundaries of the
repeats and spacers were obtained using CRISPRAlign.
Validation of the targeted assembly approach using
simulated datasets
We simulated short reads from 6 reference genomes (Azospirillum
B510, Streptococcus mutans NN2025, Deferribacter desulfuricans SSM1,
Dehalococcoides GT, Erwinia amylovora ATCC 49946, and Escherichia
coli K12 MG1655), and applied our method to attempt to assemble
the 10 known CRISPRs in these genomes. All 54 contigs
assembled by our targeted assembly approach match perfectly to
known CRISPRs in the reference genomes. We listed the genome
names, the CRISPR repeats, the coordinates of the known
CRISPRS in the reference genomes, and the coordinates of the
contigs aligned on the reference genomes in Table S7.
Datasets
We used the dataset Human Microbiome Illumina WGS Reads
(HMIGWS) Build 1.0 available at http://hmpdacc.org/HMIWGS,
and the whole-metagenome assemblies from the HMP consortium
(http://www.hmpdacc.org/). The bacterial genomes were down-
loaded from the IMG database (http://img.jgi.doe.gov/cgi-bin/m/
main.cgi), NCBI ftp site (ftp://ftp.ncbi.nih.gov/genomes), and
human microbiome project website (http://www.hmpdacc.org/
data_genomes.php). The viral genomes were downloaded from
the NCBI ftp site (http://www.ncbi.nlm.nih.gov/genomes/
GenomesGroup.cgi?taxid = 10239). Additional phage genomes
were downloaded from the PhAnToMe database site (http://
www.phantome.org/Downloads/DNA/all_sequences/).
Supporting Information
Figure S1 A network of 150 CRISPRS. The CRISPR names
were shown in each node. The CRISPR host species for each
known CRIPRS are listed in Table S2. Known CRISPRs are
shown as blue nodes (except for several CRISPRs highlighted in
green), and the novel CRISPRs identified in the HMP datasets are
shown as red nodes.
(TIF)
Figure S2 The consensus of CRISPR repeats for 6 large clusters.
See cluster ID in Figure S1. The sequence logo was prepared using
weblogo (http://weblogo.berkeley.edu/).
(TIF)
Figure S3 Distribution of CRISPRs in different body sites. The
x-axis represents 150 CRISPRs (listed in Table S2) and y-axis
represents the proportion of samples in which instances of each of
the CRISPR are found.
(TIF)
Figure S4 Cluster of spacers shared by more than eight samples.
In this map, rows are spacers (clustered at 80% identify), and the
columns are samples: cluster (a) is shared by 22 samples; cluster (b)
is shared by 23 samples; cluster (c) is shared by 12 samples; cluster
(d) is shared by 32 samples. The red lines indicate the presence of
spacers in each of the samples. Multiple lines in the same row
represent a spacer that is shared by multiple samples.
(TIF)
Figure S5 Sharing of streptococcal CRISPR spacers among
samples from 6 individuals. In this map, the rows are the 761
spacers (clustered at 80% identify; see Figure 5 for the plot using
98% identify) identified in one or more of these 6 individuals, and
the columns are samples (e.g., Stool_v1_p1 means a sample from
stool of individual 1, in visit 1; Tongue_v2_p1 indicates dataset
from tongue, individual 1, in visit 2). Buccal stands for buccal
mucosa, and SupraPlaque stands for supragingival plaque. The
red lines indicate the presence of spacers in each of the samples.
Multiple lines in the same row represent a spacer that is shared by
multiple samples.
(TIF)
Figure S6 Sharing of KoralL32 CRISPR spacers among
samples from 6 individuals. In this map, rows are the 598 spacers
(clustered at 80% identify), and the columns are samples (e.g.,
Stool_v1_p1 means a sample from stool of individual 1, in visit 1;
tongue_v2_p1 indicates dataset from tongue, individual 1, in visit
2). The red lines indicate the presence of spacers in each of the
samples. Multiple lines in the same row represent a spacer that is
shared by multiple samples.
(TIF)
Figure S7 Sequence logos showing the short sequence motifs in
regions adjacent to proto-spacers in the viral genomes for three
CRISPRs.
(TIF)
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Table S1 List of 150 CRISPRs studied in this manuscript and
the targeted assembly results in the HMP datasets.
(DOCX)
Table S2 List of CRISPRs that are identified from the reference
genomes, and their cross-references in the CRISPRdb.
(DOCX)
Table S3 List of numbers of datasets from different body sites
that have reads (the first number) or CRISPRs (the second
number) identified for each CRISPR.
(XLSX)
Table S4 List of viral genomes and their accession IDs plotted in
Figure 6A.
(DOCX)
Table S5 List of viral genomes sharing high sequence similarities
($90% identify over 30 bps) with CRISPR spacers.
(DOCX)
Table S6 List of plasmids sharing high sequence similarities
($90%) with CRISPR spacers.
(DOCX)
Table S7 Targeted assembly results of 10 CRISPRs using reads
simulated from 6 genomes.
(DOCX)
Acknowledgments
The authors thank the Human Microbiome Project (HMP) consortium for
providing the sequencing data and the whole-metagenome assemblies of
the HMP datasets, and the anonymous reviewers for their helpful
suggestions.
Author Contributions
Conceived and designed the experiments: MR YY. Performed the
experiments: MR Y-WW YY. Analyzed the data: MR Y-WW HT TGD
YY. Wrote the paper: MR Y-WW HT TGD YY.
References
1. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, et al. (2007)
CRISPR provides acquired resistance against viruses in prokaryotes. Science
315: 1709–1712.
2. Horvath P, Barrangou R (2010) CRISPR/Cas, the immune system of bacteria
and archaea. Science 327: 167–170.
3. Jansen R, Embden JD, Gaastra W, Schouls LM (2002) Identification of genes
that are associated with DNA repeats in prokaryotes. Mol Microbiol 43:
1565–1575.
4. Sorek R, Kunin V, Hugenholtz P (2008) CRISPR–a widespread system that
provides acquired resistance against phages in bacteria and archaea. Nat Rev
Microbiol 6: 181–186.
5. van der Oost J, Jore MM, Westra ER, Lundgren M, Brouns SJ (2009) CRISPR-based
adaptive and heritable immunity in prokaryotes. Trends Biochem Sci 34: 401–407.
6. Grissa I, Vergnaud G, Pourcel C (2007) The CRISPRdb database and tools to
display CRISPRs and to generate dictionaries of spacers and repeats. BMC
Bioinformatics 8: 172.
7. Kunin V, Sorek R, Hugenholtz P (2007) Evolutionary conservation of sequence
and secondary structures in CRISPR repeats. Genome Biol 8: R61.
8. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, et al. (2011)
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase
III. Nature 471: 602–607.
9. Deveau H, Garneau JE, Moineau S (2010) CRISPR/Cas System and Its Role in
Phage-Bacteria Interactions. Annual Review of Microbiology 64: 475–493.
10. Deveau H, Barrangou R, Garneau JE, Labonte´ J, Fremaux C, et al. (2008)
Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilis.
Journal of Bacteriology 190: 1390–1400.
11. Chakraborty S, Snijders AP, Chakravorty R, Ahmed M, Tarek AM, et al. (2010)
Comparative network clustering of direct repeats (DRs) and cas genes confirms
the possibility of the horizontal transfer of CRISPR locus among bacteria. Mol
Phylogenet Evol 56: 878–887.
12. Godde J, Bickerton A (2006) The Repetitive DNA Elements Called CRISPRs
and Their Associated Genes: Evidence of Horizontal Transfer Among
Prokaryotes. Journal of Molecular evolution 62: 718–729.
13. Andersson AF, Banfield JF (2008) Virus population dynamics and acquired virus
resistance in natural microbial communities. Science 320: 1047–1050.
14. Heidelberg JF, Nelson WC, Schoenfeld T, Bhaya D (2009) Germ warfare in a
microbial mat community: CRISPRs provide insights into the co-evolution of
host and viral genomes. PLoS ONE 4: e4169. doi:10.1371/journal.pone.
0004169.
15. Held NL, Whitaker RJ (2009) Viral biogeography revealed by signatures in
Sulfolobus islandicus genomes. Environ Microbiol 11: 457–466.
16. Kunin V, He S, Warnecke F, Peterson SB, Garcia Martin H, et al. (2008) A
bacterial metapopulation adapts locally to phage predation despite global
dispersal. Genome Research 18: 293–297.
17. Hawley DM, Altize SM (2011) Disease ecology meets ecological immunology:
understanding the links between organismal immunity and infection dynamics in
natural populations. . Functional Ecology 25: 48–60.
18. Keesing F, Holt RD, Ostfeld RS (2006) Effects of species diversity on disease
risk. Ecol Lett 9: 485–498.
19. Wolinska J, Spaak P (2009) The cost of being common: evidence from natural
Daphnia populations. Evolution 63: 1893–1901.
20. Hamilton WD, Axelrod R, Tanese R (1990) Sexual reproduction as an
adaptation to resist parasites (a review). Proc Natl Acad Sci USA 87: 3566–3573.
21. Angly FE, Felts B, Breitbart M, Salamon P, Edwards RA, et al. (2006) The
marine viromes of four oceanic regions. PLoS Biol 4: e368. doi:10.1371/
journal.pbio.0040368.
22. Parada V, Baudoux AC, Sintes E, Weinbauer MG, Herndl GJ (2008) Dynamics and
diversity of newly produced virioplankton in the North Sea. ISME J 2: 924–936.
23. Ventura M, Sozzi T, Turroni F, Matteuzzi D, van Sinderen D (2010) The
impact of bacteriophages on probiotic bacteria and gut microbiota diversity.
Genes Nutr.
24. Woodford N, Turton JF, Livermore DM (2011) Multiresistant Gram-negative
bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.
FEMS Microbiol Rev.
25. Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, et al. (2010)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid
DNA. Nature 468: 67–71.
26. Pride DT, Sun CL, Salzman J, Rao N, Loomer P, et al. (2011) Analysis of
streptococcal CRISPRs from human saliva reveals substantial sequence diversity
within and between subjects over time. Genome Research 21: 126–136.
27. Grissa I, Vergnaud G, Pourcel C (2007) CRISPRFinder: a web tool to identify
clustered regularly interspaced short palindromic repeats. Nucleic Acids Res 35:
W25–57.
28. Bland C, Ramsey T, Sabree F, Lowe M, Brown K, et al. (2007) CRISPR
Recognition Tool (CRT): a tool for automatic detection of clustered regularly
interspaced palindromic repeats. BMC Bioinformatics 8: 209.
29. Edgar R (2007) PILER-CR: Fast and accurate identification of CRISPR repeats.
BMC Bioinformatics 8: 18.
30. Rousseau C, Gonnet M, Le Romancer M, Nicolas J (2009) CRISPI: a CRISPR
interactive database. Bioinformatics 25: 3317–3318.
31. Rho M, Tang H, Ye Y (2010) FragGeneScan: predicting genes in short and
error-prone reads. Nucl Acids Res doi:10.1093/nar/gkq747.
32. Bhally HS, Lema C, Romagnoli M, Borek A, Wakefield T, et al. (2005)
Leptotrichia buccalis bacteremia in two patients with acute myelogenous
leukemia. Anaerobe 11: 350–353.
33. Haft DH, Selengut J, Mongodin EF, Nelson KE (2005) A guild of 45 CRISPR-
associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in
prokaryotic genomes. PLoS Comput Biol 1: e60. doi:10.1371/journal.pcbi.0010060.
34. Martı´n R, Escobedo S, Sua´rez Juan E (2010) Induction, structural character-
ization, and genome sequence of Lv1, a prophage from a human vaginal
Lactobacillus jensenii strain. Int Microbiol 13: 113–121.
35. Marraffini LA, Sontheimer EJ (2010) CRISPR interference: RNA-directed
adaptive immunity in bacteria and archaea. Nat Rev Genet 11: 181–190.
36. Mojica FJM, Dı´ez-Villasen˜or Cs, Garcı´a-Martı´nez Js, Soria E (2005) Intervening
sequences of regularly spaced prokaryotic repeats derive from foreign genetic
elements. Journal of Molecular evolution 60: 174–182.
37. Marraffini LA, Sontheimer EJ (2008) CRISPR interference limits horizontal
gene transfer in Staphylococci by targeting DNA. Science 322: 1843–1845.
38. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Almendros C (2008) Short
motif sequences determine the targets of the prokaryotic CRISPR defence
system. Microbiology 155: 733–740.
39. Li W, Jaroszewski L, Godzik A (2001) Clustering of highly homologous sequences
to reduce the size of large protein databases. Bioinformatics 17: 282–283.
40. Li R, Zhu H, Ruan J, Qian W, Fang X, et al. (2010) De novo assembly of human
genomes with massively parallel short read sequencing. Genome Res 20: 265–272.
41. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial
gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
42. The Human Microbiome Consortium (2012) Structure, Function and Diversity
of Human Microbiome in an Adult Reference Population. Nature: doi:10.1038/
nature11234.
43. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2011) Cytoscape 2.8:
new features for data integration and network visualization. Bioinformatics 27:
431–432.
Diverse CRISPRs Evolving in Human Microbiomes
PLoS Genetics | www.plosgenetics.org 12 June 2012 | Volume 8 | Issue 6 | e1002441
